Physician profile
Katherine Kelle Tillman
NPI 1720648140
$2,807.76
in general payments reported to CMS, 2019-2025
6 companies · $547 in 2025
The $547 reported for 2025 was more than what 99% of Administrator providers received nationally (typical 2025 total: $37.50).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $532 · 2022: $909 · 2023: $124 · 2024: $695 · 2025: $547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $936 · Consulting Fee: $430.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $936.07 |
| Consulting Fee | $430.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,856.51 | 2021-2025 | Biktarvy, Yeztugo |
| Viiv Healthcare Company | $419.48 | 2021-2024 | Dovato |
| Pharming Healthcare, INC. | $171.68 | 2025 | Ruconest |
| Janssen Biotech, INC. | $136.36 | 2022-2023 | Symtuza |
| Takeda Pharmaceuticals U.S.A., INC. | $124.73 | 2025 | Cuvitru |
| Janssen Products, Lp | $99.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Tillman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.